Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

SYRE

Spyre Therapeutics Inc

Jun 11 • 04:00PM ET

80.77

+5.69 7.58 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: BMRN RYTM APGE KRYS KYMR NUVL AXSM MDGL VKTX NBIX

| Held by: VTI IWM XBI VXF IBB IWO VTWO SCHA IWN VHT

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.36	Insider Own	10.95%	Shs Outstand	78.84M	Perf Week	2.92%
Market Cap	7.01B	Forward P/E	-	EPS next Y	-3.15	Insider Trans	-3.01%	Shs Float	77.33M	Perf Month	7.64%
Enterprise Value	6.43B	PEG	-	EPS next Q	-0.73	Inst Own	87.15%	Short Float	16.33%	Perf Quarter	99.88%
Income	-168.74M	P/S	-	EPS this Y	-46.83%	Inst Trans	1.14%	Short Ratio	11.03	Perf Half Y	139.82%
Sales	0.00M	P/B	12.37	EPS next Y	-8.27%	ROA	-25.30%	Short Interest	12.63M	Perf YTD	146.55%
Book/sh	6.53	P/C	9.46	EPS next 5Y	-22.13%	ROE	-29.26%	52W High	79.54 1.55%	Perf Year	348.72%
Cash/sh	8.54	P/FCF	-	EPS past 3/5Y	57.01% 44.61%	ROIC	-25.15%	52W Low	13.93 479.82%	Perf 3Y	2311.04%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.75% 6.30%	Perf 5Y	-51.05%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	22.31%	Oper. Margin	-	ATR (14)	4.71	Perf 10Y	-48.55%
Dividend Ex-Date	-	Quick Ratio	8.97	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	61.71	Recom	1.06
Dividend Gr. 3/5Y	- -	Current Ratio	8.97	EPS Q/Q	-46.71%	SMA20	9.97%	Beta	3.01	Target Price	96.07
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	16.67%	Rel Volume	1.10	Prev Close	75.08
Employees	102	LT Debt/Eq	0.00	Earnings	May 05 BMO	SMA200	106.10%	Avg Volume	1.15M	Price	80.77
IPO	Apr 07, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-11.18% -	Trades		Volume	1,260,160	Change	7.58%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)